Clinical trial · Observational
Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology
NCT06335277CI-TRIAL-00075480unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients eligible undergoing total body irradiation as candidates for bone marrow or peripheral stem cell transplant.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Aplastic Anemia | — | UNRESOLVED | — |
| Leukemia | Leukemia | ONTOLOGY_EXACT | 0.90 |
| Leukemia, Acute | Acute Leukemia | ONTOLOGY_EXACT | 0.90 |
| Leukemia, Chronic | Chronic Leukemia | ONTOLOGY_EXACT | 0.98 |
| Lymphoma | Lymphoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Total Body Irradiation (TBI)
- description
- Patients treated at European Institute of Oncology with Total Body Irradiation (TBI)
Primary outcomes (2)
- measure
- Overall Survival
- timeFrame
- 5 years
- description
- Number of patients death
- measure
- Disease free survival
- timeFrame
- 5 years
- description
- Number of oncological event (local recurrence, distant metastasis, other primary tumor)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients undergoing total body irradiation as candidates for bone marrow or peripheral stem cell transplantation. 2. Signed informed consent Exclusion Criteria: * Patients who do not undergo total body irradiation
References
Publications (0)
Data not yet available
No reference posted for this study.